At the intersection of science, technology, and patient care, Teva Pharmaceuticals is harnessing the power of artificial intelligence (AI) and digital innovation to reshape the future of healthcare.

From accelerating drug discovery and development to enhancing diagnosis and treatment, Teva’s approach is forward-thinking and deeply patient-focused. By integrating cutting-edge technologies and fostering strategic global collaborations, Teva is not only advancing how medicines are made, but also redefining how they are delivered, experienced, and personalized for people around the world.

4. Staying Ahead of Trends with Data Science and Smart Devices

Keeping abreast of new trends and discoveries is all part of our teams’ work. Data scientist Michal Melamed highlights the latest tech trends she's excited about, from discovering big data insights to using smart watches to personalize treatment plans.

5. Advancing AI-Driven Drug Discovery with AION Labs

With a mission to revolutionize drug discovery and development through AI and big data, AION Labs is a collaborative venture of leading pharmaceutical and tech companies, supported by the Israel Innovation Authority. Identifying key healthcare challenges and inviting innovative solutions, this collaborative model seeks to expedite the creation of new medicines, making the process faster, more cost-effective, and precise. ​

6. Leading Innovation in Combination Drug-Device Therapies

Teva is a leading producer of combination products - integrated drug-device therapies such as patches and implants that aim to improve treatment and patient comfort. Manufacturing over 100 million units annually, Teva leverages its global, in-house engineering teams to innovate across generics, biosimilars, and new medicines.

7. Prioritizing Patient-Centric Drug Delivery

Keeping an eye on the latest trends in drug delivery, Director of Global Technology Innovation Mark DeStefano highlights patient-centric innovation for easier use, sustainability through eco-friendly materials and processes, and digital health integration to boost treatment adherence and deliver valuable data to healthcare providers.

8. Developing New Treatments Through Strategic Partnerships

Teva accelerates the development and delivery of innovative therapies through strategic partnerships with companies across the healthcare ecosystem. By combining complementary expertise and resources, these collaborations help bring medicines to patients faster, expand access, and address critical unmet needs. 

For example, Teva and Sanofi are collaborating to develop an important new treatment for Irritable Bowel Disease. While current IBD treatments aim to induce remission and prevent complications, their effectiveness varies among patients and may diminish over time.